Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions
Medicinal Research Reviews · 2026-07 · 46 (4) · 853-895
DOI: 10.1002/med.70034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 23.02.2026. Verfasst von Linyue Bai und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Metabolic Dysregulation & prevention and Treatment of Esophageal Cancer, Key Laboratory of Advanced Drug preparation Technolo…. Hauptthemen laut MEDLINE: Ferroptosis, Small Molecule Libraries. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 329 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province, National Natural Science Foundation of China, Key Scientific and Technological Projects of Henan Province.
Abstract (Originalsprache)
Ferroptosis is an iron‐dependent cell death characterized by the disorder of iron homeostasis and the accumulation of lipid peroxidation, which trigger a cascade of events resulting in cell death. This process has a dual regulatory effect in the evolution of diseases, which can not only attenuate the progress of diseases, but also become a promoting force to accelerate pathological alterations, and widely participate in the occurrence and development of multiple diseases. In recent years, there has been a growing body of research identifying regulators—both inducers and inhibitors—that target the mechanisms of ferroptosis, particularly in the field of anti‐tumor drug research. This review systematically elucidates the regulatory mechanisms underlying ferroptosis (e.g., iron metabolism, lipid peroxidation, system Xc − /GSH/GPX4 axis) and examines the role of ferroptosis in the pathogenesis of various diseases, such as cancer, neurodegenerative diseases, liver and kidney diseases, and cardiovascular diseases. Additionally, we discussed the therapeutic applications of novel inducers and inhibitors of ferroptosis in recent years, offering critical insights and directions for further researching on the mechanism of ferroptosis and targeted drugs for ferroptosis‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Metabolic Dysregulation & prevention and Treatment of Esophageal Cancer, Key Laboratory of Advanced Drug preparation Technologies, Ministry of Education, Key Laboratory of Henan Province for Smal…
- Department of Pharmacy, The First People's Hospital of Dali, Dali, China.
- Jiang Su Key Laboratory of Drug Design and Optimization and state key Laboratory of Natural Medicines, China pharmaceutical University, Nanjing, China.
- Institute of Chemistry Co. Ltd., Henan Academy of Sciences, Zhengzhou, China.
ORCID-Profile: Hong-Min Liu, Xing-Jie Dai, Siqi Feng
Förderung
- Natural Science Foundation of Henan Province
- National Natural Science Foundation of China
- Key Scientific and Technological Projects of Henan Province
- Henan Academy of Sciences
Zitieren
APA
Bai, L., Shen, L., Zhang, Q., Hu, Z., Tang, Y., Fu, M., Fan, Y., Wang, H., Liu, H. M., Dai, X. J., & Feng, S. (2026). Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions. Medicinal Research Reviews, 46(4), 853-895. https://doi.org/10.1002/med.70034
Vancouver
Bai L, Shen L, Zhang Q, Hu Z, Tang Y, Fu M, et al. Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions. Medicinal Research Reviews. 2026;46(4):853-895. doi:10.1002/med.70034
BibTeX
@article{Bai2026,
author = {Bai, Linyue and Shen, Liang and Zhang, Qianqian and Hu, Zhuang and Tang, Yanjun and Fu, Mengjie and Fan, Yange and Wang, Huifeng and Liu, Hong-Min and Dai, Xing-Jie and Feng, Siqi},
title = {Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions},
journal = {Medicinal Research Reviews},
year = {2026},
volume = {46},
number = {4},
pages = {853--895},
doi = {10.1002/med.70034}
}
EUVIMED